top of page
RETINAEYEICON.png

Macular Telangiectasia (MacTel, Type 2)

A bilateral condition involving abnormal, dilated capillaries and progressive degeneration of the retina around the macula, of unclear underlying cause. It typically affects adults in mid-to-later life.

Macular Telangiectasia (MacTel, Type 2).jpeg

Symptoms

Gradual blurring of central vision

​

Difficulty reading, particularly missing letters or words

​

Mild metamorphopsia​​

​

Symptoms are often subtle early on and slowly progressive

Findings

Retinal graying and loss of transparency temporal to the fovea​

 

​Right-angle venules and telangiectatic capillaries

 

​Loss of outer retinal layers and cavitation on OCT

​

Late leakage on fluorescein angiography

​

Possible neovascularization in advanced cases

Treatments

ENCELTO (revakinagene taroretcel-lwey): an FDA-approved, surgically implanted encapsulated cell therapy that delivers ciliary neurotrophic factor (CNTF) to slow photoreceptor loss, for progressive MacTel cases

​

Observation and monitoring: for patients not pursuing implant therapy, ​

 

​Anti-VEGF injections: reserved for eyes that develop neovascularization

​

​​​

Low vision aids: for reading and near-vision support

bottom of page